Cabergoline Tablets

Formulated to target prolactin levels and indicated to support hormonal balance, this dopamine agonist is utilized to manage endocrine disorders.

Strengths: 0.25 · 0.5mg

Women's Health icon Women's Health Hormone Therapy icon Hormone Therapy Cabergoline icon Cabergoline

Where to Check Availability

Medicine details

Conditions
Alternative names

Dostinex

Therapeutic class

Dopamine agonist

Pharmacological class

Ergot derivative

Minor side effects

nausea; dizziness; headache

Moderate side effects

constipation; abdominal pain; fatigue

Dosage forms

Tablet

Administration route

Oral use

Prescription status

POM

Manufacturer

Pfizer

Onset Time

2–3 hours

Duration

14 days

Storage instructions

Store below 25°C in a dry place.

Drug interactions

antipsychotics; metoclopramide; macrolide antibiotics

Age restrictions

Not for children.

Contraindications

hypersensitivity to ergot alkaloids; uncontrolled hypertension; severe hepatic impairment; history of pulmonary fibrosis

Precautions and warnings

monitor blood pressure regularly; inform doctor of impulse control issues; may cause drowsiness

Serious side effects

cardiac valvulopathy — requires immediate medical attention; hallucinations — requires immediate medical attention; psychotic disorders — requires immediate medical attention

Patient summary

Formulated to target prolactin levels and indicated to support hormonal balance, this dopamine agonist is utilized to manage endocrine disorders.

Mechanism of action

Cabergoline acts as a potent and selective dopamine D2-receptor agonist in the pituitary gland, directly inhibiting the secretion of prolactin. It also provides stimulation for dopaminergic pathways involved in motor control.

Pregnancy and breastfeeding

Pregnancy: Should be avoided. Breastfeeding: Not recommended as it inhibits lactation.

Cabergoline Tablets

Formulated to target prolactin levels and indicated to support hormonal balance, this dopamine agonist is utilized to manage endocrine disorders.

Editorial Notes

  • Active ingredient(s): Cabergoline
  • Listed indication(s): Hyperprolactinaemia, Parkinson’s Disease

Usually available as

  • 16 tablets - 0.25 mg1438-0-25-mg-17301
  • 8 tablets - 0.5 mg1438-0-5-mg-17296